Get startedLog in
    Picture of Sihuan Pharmaceutical Holdings logo

    460 — Sihuan Pharmaceutical Holdings Income Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Sihuan Pharmaceutical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2020
    December 31st
    R2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS    		—
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue2,4643,0382,1811,8611,901
    Cost of Revenue
    Gross Profit1,9142,4301,4881,2961,242
    Selling / General / Administrative Expenses
    Research And Development
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses1,6772,2664,0121,6992,039
    Operating Profit787772-1,831162-138
    Total Net Non Operating Interest Income / Expense
    Net Income Before Taxes766496-2,123-161-428
    Provision for Income Taxes
    Net Income After Taxes547243-2,320-258-472
    Minority Interest
    Net Income Before Extraordinary Items
    Extraordinary Items
    Net Income473417-1,915-54-217
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income473417-1,915-54-217
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS0.0420.048-0.101-0.008-0.027
    Dividends per Share
    Special Dividends per Share